Risk factors and clinical prediction models for low-level viremia in people living with HIV receiving antiretroviral therapy: an 11-year retrospective study
Frontiers in Microbiology · 01.11.2024 · 15
DOI: 10.3389/fmicb.2024.1451201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 01.11.2024. Verfasst von Wenhui Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection, Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study explores the risk factors for low-level viremia (LLV) occurrence after ART and develops a risk prediction model.
Method
Clinical data and laboratory indicators of people living with HIV (PLWH) at Hangzhou Xixi Hospital from 5 April 2011 to 29 December 2022 were collected. LASSO Cox regression and multivariate Cox regression analysis were performed to identify laboratory indicators and establish a nomogram for predicting LLV occurrence. The nomogram’s discrimination and calibration were assessed via ROC curve and calibration plots. The concordance index (C-index) and decision curve analysis (DCA) were used to evaluate its effectiveness.
Result
Predictive factors, namely, age, ART delay time, white blood cell (WBC) count, baseline CD4 + T-cell count (baseline CD4), baseline viral load (baseline VL), and total bilirubin (TBIL), were incorporated into the nomogram to develop a risk prediction model. The optimal model (which includes 6 variables) had an AUC for LLV after 1-year, 3-year, and 5-year of listing of 0.68 (95% CI, 0.61–0.69), 0.69 (95% CI, 0.65–0.70), and 0.70 (95% CI, 0.66–0.71), respectively. The calibration curve showed high consistency between predicted and actual observations. The C-index and DCA indicated superior prediction performance of the nomogram. There was a significant difference in CD4 levels between LLV and non-LLV groups during the follow-up time. The dynamic SCR, ALT, TG and BG levels and occurrence of complications differed significantly between the high- and low-risk groups.
Conclusion
A simple-to-use nomogram containing 6 routinely detected variables was developed for predicting LLV occurrence in PLWH after ART.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infection, Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Nursing, Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
- Medical Laboratory, Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
- Clinical Research Laboratory, Hangzhou Xixi Hospital, Zhejiang University of Traditional Chinese Medicine, Hangzhou, China.
Zitieren
APA
Zhang, W., Shi, J., Wang, Y., Li, E., Yan, D., Zhang, Z., Zhu, M., Yu, J., & Wang, Y. (2024). Risk factors and clinical prediction models for low-level viremia in people living with HIV receiving antiretroviral therapy: an 11-year retrospective study. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1451201
Vancouver
Zhang W, Shi J, Wang Y, Li E, Yan D, Zhang Z, et al. Risk factors and clinical prediction models for low-level viremia in people living with HIV receiving antiretroviral therapy: an 11-year retrospective study. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1451201
BibTeX
@article{Zhang2024,
author = {Zhang, Wenhui and Shi, Jinchuan and Wang, Ying and Li, Er and Yan, Dingyan and Zhang, Zhongdong and Zhu, Mingli and Yu, Jianhua and Wang, Yi},
title = {Risk factors and clinical prediction models for low-level viremia in people living with HIV receiving antiretroviral therapy: an 11-year retrospective study},
journal = {Frontiers in Microbiology},
year = {2024},
volume = {15},
doi = {10.3389/fmicb.2024.1451201}
}
EUVIMED